Automated Nuclei Segmentation of Breast Cancer Histopathology

Automated detection and segmentation of cell nuclei is an essential step in breast cancer histopathology, so that there is improved accuracy, speed, level of automation and adaptability to new application. The goal of this paper is to develop efficient and accurate algorithms for detecting and segmenting cell nuclei in 2-D histological images. In this paper we will implement the utility of our nuclear segmentation algorithm in accurate extraction of nuclear features for automated grading of (a) breast cancer, and (b) distinguishing between cancerous and benign breast histology specimens. In order to address the issue the scheme integrates image information across three different scales: (1) low level information based on pixel values, (2) high-level information based on relationships between pixels for object detection, and(3)domain-specific information based on relationships between histological structures. Low-level information is utilized by a Bayesian Classifier to generate likelihood that each pixel belongs to an object of interest. High-level information is extracted in two ways: (i) by a level-set algorithm, where a contour is evolved in the likelihood scenes generated by the Bayesian classifier to identify object boundaries, and (ii) by a template matching algorithm, where shape models are used to identify glands and nuclei from the low-level likelihood scenes. Structural constraints are imposed via domain specific knowledge in order to verify whether the detected objects do indeed belong to structures of interest. The efficiency of our segmentation algorithm is evaluated by comparing breast cancer grading and benign vs. cancer discrimination accuracies with corresponding accuracies obtained via manual detection and segmentation of glands and nuclei

Machine learning methods for histopathological image analysis

Abundant accumulation of digital histopathological images has led to the increased demand for their analysis, such as computer-aided diagnosis using machine learning techniques. However, digital pathological images and related tasks have some issues to be considered. In this mini-review, we introduce the application of digital pathological image analysis using machine learning algorithms, address some problems specific to such analysis, and propose possible solutions.Comment: 23 pages, 4 figure

Machine-learning-based evaluation of intratumoral heterogeneity and tumor-stroma interface for clinical guidance

© The Author(s), 2021. This article is distributed under the terms of the Creative Commons Attribution License. The definitive version was published in Laurinavicius, A., Rasmusson, A., Plancoulaine, B., Shribak, M., & Levenson, R. Machine-learning-based evaluation of intratumoral heterogeneity and tumor-stroma interface for clinical guidance. American Journal of Pathology, 191(10), (2021): 1724–1731, https://doi.org/10.1016/j.ajpath.2021.04.008.Assessment of intratumoral heterogeneity and tumor-host interaction within the tumor microenvironment is becoming increasingly important for innovative cancer therapy decisions because of the unique information it can generate about the state of the disease. However, its assessment and quantification are limited by ambiguous definitions of the tumor-host interface and by human cognitive capacity in current pathology practice. Advances in machine learning and artificial intelligence have opened the field of digital pathology to novel tissue image analytics and feature extraction for generation of high-capacity computational disease management models. A particular benefit is expected from machine-learning applications that can perform extraction and quantification of subvisual features of both intratumoral heterogeneity and tumor microenvironment aspects. These methods generate information about cancer cell subpopulation heterogeneity, potential tumor-host interactions, and tissue microarchitecture, derived from morphologically resolved content using both explicit and implicit features. Several studies have achieved promising diagnostic, prognostic, and predictive artificial intelligence models that often outperform current clinical and pathology criteria. However, further effort is needed for clinical adoption of such methods through development of standardizable high-capacity workflows and proper validation studies.Supported by the European Social Fund grant 09.3.3-LMT-K-712

Representación de imágenes de histopatología utilizada en tareas de análisis automático: estado del arte

This paper presents a review of the state-of-the-art in histopathology image representation used in automatic image analysis tasks. Automatic analysis of histopathology images is important for building computer-assisted diagnosis tools, automatic image enhancing systems and virtual microscopy systems, among other applications. Histopathology images have a rich mix of visual patterns with particularities that make them difficult to analyze. The paper discusses these particularities, the acquisition process and the challenges found when doing automatic analysis. Second an overview of recent works and methods addressed to deal with visual content representation in different automatic image analysis tasks is presented. Third an overview of applications of image representation methods in several medical domains and tasks is presented. Finally, the paper concludes with current trends of automatic analysis of histopathology images like digital pathology

INTERNATIONAL JOURNAL OF PURE AND APPLIED RESEARCH IN ENGINEERING AND TECHNOLOGY A PATH FOR HORIZING YOUR INNOVATIVE WORK INTENSITY BASED NUCLEI SEGMENTATION OF CANCER CELL

Abstract Automated detection and segmentation of cell nuclei is an essential step in breast cancer cell for improved accuracy, speed, level of automation and adaptability to new application. The goal of this paper is to develop efficient and accurate algorithms for detecting and segmenting cell nuclei in 2-D pathological images. In this paper we will implement the utility of our nuclear segmentation algorithm in accurate extraction of nuclear features for automated grading of (a) breast cancer, and (b) distinguishing between cancerous and benign breast histology specimens. In order to address the issue the scheme integrates image information across three different scales: (1) low level information based on pixel values, (2) highlevel information based on relationships between pixels for object detection, and (3)Intensity-specific information based on relationships between pathological sample. Low-level information is utilized to generate likelihood that each pixel belongs to an object of interest. Highlevel information is extracted by a level-set algorithm, where a contour is evolved in the likelihood scenes generated by the Low-level information to identify object boundaries, and to identify nuclei from the low-level likelihood scenes. Structural limitations are imposed via intensity based specific knowledge in order to verify whether the detected objects do indeed belong to structures of interest. The efficiency of our segmentation algorithm is evaluated by comparing breast cancer grading and automated benign cancer detection of nuclei with corresponding accuracies obtained via manual detection and segmentation of nuclei

Histopathological image analysis : a review

Over the past decade, dramatic increases in computational power and improvement in image analysis algorithms have allowed the development of powerful computer-assisted analytical approaches to radiological data. With the recent advent of whole slide digital scanners, tissue histopathology slides can now be digitized and stored in digital image form. Consequently, digitized tissue histopathology has now become amenable to the application of computerized image analysis and machine learning techniques. Analogous to the role of computer-assisted diagnosis (CAD) algorithms in medical imaging to complement the opinion of a radiologist, CAD algorithms have begun to be developed for disease detection, diagnosis, and prognosis prediction to complement the opinion of the pathologist. In this paper, we review the recent state of the art CAD technology for digitized histopathology. This paper also briefly describes the development and application of novel image analysis technology for a few specific histopathology related problems being pursued in the United States and Europe

Detection of HER2 from Haematoxylin-Eosin Slides Through a Cascade of Deep Learning Classifiers via Multi-Instance Learning

Breast cancer is the most frequently diagnosed cancer in woman. The correct identification of the HER2 receptor is a matter of major importance when dealing with breast cancer: an over-expression of HER2 is associated with aggressive clinical behaviour; moreover, HER2 targeted therapy results in a significant improvement in the overall survival rate. In this work, we employ a pipeline based on a cascade of deep neural network classifiers and multi-instance learning to detect the presence of HER2 from Haematoxylin–Eosin slides, which partly mimics the pathologist’s behaviour by first recognizing cancer and then evaluating HER2. Our results show that the proposed system presents a good overall effectiveness. Furthermore, the system design is prone to further improvements that can be easily deployed in order to increase the effectiveness score.Eduardo Conde-Sousa was supported by the project PPBI-POCI-01-0145-FEDER-022122, in the scope of Fundação para a Ciência e Tecnologia, Portugal (FCT) National Roadmap of Research Infrastructures

Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: a report of the international immuno-oncology biomarker working group

The clinical significance of the tumor-immune interaction in breast cancer is now established, and tumor-infiltrating lymphocytes (TILs) have emerged as predictive and prognostic biomarkers for patients with triple-negative (estrogen receptor, progesterone receptor, and HER2-negative) breast cancer and HER2-positive breast cancer. How computational assessments of TILs might complement manual TIL assessment in trial and daily practices is currently debated. Recent efforts to use machine learning (ML) to automatically evaluate TILs have shown promising results. We review state-of-the-art approaches and identify pitfalls and challenges of automated TIL evaluation by studying the root cause of ML discordances in comparison to manual TIL quantification. We categorize our findings into four main topics: (1) technical slide issues, (2) ML and image analysis aspects, (3) data challenges, and (4) validation issues. The main reason for discordant assessments is the inclusion of false-positive areas or cells identified by performance on certain tissue patterns or design choices in the computational implementation. To aid the adoption of ML for TIL assessment, we provide an in-depth discussion of ML and image analysis, including validation issues that need to be considered before reliable computational reporting of TILs can be incorporated into the trial and routine clinical management of patients with triple-negative breast cancer. © 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland